Sophia Genetics SA (NAS:SOPH)
$ 3.65 -0.34 (-8.52%) Market Cap: 242.50 Mil Enterprise Value: 200.98 Mil PE Ratio: 0 PB Ratio: 2.13 GF Score: 56/100

Full Year 2021 Sophia Genetics SA Earnings Call Transcript

Mar 15, 2022 / 12:30PM GMT
Release Date Price: $8.21 (-9.68%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the SOPHiA GENETICS Fourth Quarter 2021 Earnings Conference Call. (Operator Instructions)

I would now like to turn the call over to your host, Jennifer Pottage, Head of Investor Relations. You may begin.

Jennifer Pottage
SOPHiA GENETICS SA - Head of IR

Good morning, and thank you for joining us on SOPHiA GENETICS Q4 Fiscal '21 Earnings Call. My name is Jennifer Pottage, and I am the Head of Investor Relations at SOPHiA. Joining me today are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; Peter Casasanto, our Chief Biopharma Officer; and Ross Muken, our Chief Financial Officer.

Before we get started, I would like to remind you that management will make statements during this call that are forward-looking within the scope of U.S. federal security laws. These statements are based on management's current views and assumptions which are subject to material risks and uncertainties that could cause actual results or events to materially differ from those projected.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot